Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2009

View Archived Issues

ZymoGenetics divulges novel antipsoriatic ztnfr14 antagonists

New humaneered anti-factor B antibodies reported in recent Taligen patent

GSK reports novel AMPA receptor modulators with antipsychotic properties

Recent Merck & Co. patent discloses a new series of polypeptides with antibacterial properties

New Chlamydia vaccine patented by the Thrombosis Research Institute

UCB and Wilex sign strategic alliance to develop UCB's preclinical oncology portfolio

Array BioPharma initiates phase I clinical trial for MEK inhibitor ARRY-300

TopiGen reports phase II TPI-ASM-8 results in asthma patients

Cara commences phase II proof-of-concept trial in acute postoperative pain

Cytokinetics presents update on muscle biology research and development programs

Genzyme and Isis commence several mipomersen trials

Solace initiates phase IIa glial cell modulator trial in postherpetic neuralgia

InterMune reports results from ITMN-191 triple combination study

Ardea presents positive results from phase I RDEA-594 study

Synvista Therapeutics progresses phase II clinical trial program for alagebrium

Clinical investigation of Diasome's hepatic-directed vesicle-insulin advances

Mechanism behind leptin resistance clarified, possible treatments tested in vivo

FK-1706 shows promise in painful diabetic neuropathy

Cubist and Alnylam form strategic collaboration for RNAi therapeutics targeting RSV

Medtronic to acquire Ablation Frontiers for USD 225 million

Esteve signs research partnership for development of AIDS vaccine

Pharmasset and Roche agree with FDA on final design of phase IIb trial of R-7128 in HCV

ISMB authorizes completion of BioLineRx's phase I/II study of BL-1040 in MI

Novartis initiates dosing in phase IIb trial of Albuferon in chronic hepatitis C

Anthera completes enrollment and dosing in FRANCIS clinical trial of varespladib for ACS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...